Johnson & Johnson Medical Devices Companies, through French affiliate Apsis S.A.S., announced the acquisition of Orthotaxy, a privately-held developer of software-enabled surgery technologies, including a differentiated robotic-assisted surgery solution. This proprietary technology is currently in early-stage development for total and partial knee replacement, and the Johnson & Johnson Medical Devices Companies plan to broaden its application for a range of …

Three Rivers Medical, Inc. announced it has received CE Mark (Conformité Européenne) for its Rio Embolization Coil System™ and has successfully treated its first ten patients. The Rio Embolization Coil System is indicated for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The RECS is also indicated for arterial and venous …

A new era of scientific advancement is emerging at St. Jude Children’s Research Hospital with the development of a $412-million advanced research center, the institution announced. Designed as an interactive hub of exploration and discovery, the more than 625,000-square-foot center will cultivate transformative research and collaboration and attract scientists and clinicians to St. Jude. Slated to break ground in spring …

Steward Health Care System LLC finalized a public-private partnership to deliver exceptional health care to the people of Malta. Steward, which is physician-led and the largest private hospital operator in the United States, is now the government of Malta’s health care partner and will run a number of public medical facilities in the country. “Steward’s innovative care model has successfully …

Photocure ASA, announced that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light Cystoscopy (BLC™) with Cysview® to include Flexible Cystoscopes, which are used in the ongoing surveillance of patients with bladder cancer. This is the only combination of drug and device approved for the detection of bladder …

Second Sight Medical Products announced market entry into Singapore, with the first patient implanted with the Company’s Argus® II Retinal Prosthesis System (“Argus II”). The implantation was facilitated by the Company’s exclusive distribution partner in Singapore, Mandarin Opto-Medic Co Pte Ltd. “We are delighted to have completed our first Argus II surgery in Singapore, in collaboration with another leading international …

INtuitive Health announces expansion into the Indianapolis market in partnership with Riverview Health. The newly formed joint venture will build four new retail clinics that offer both 24/7 emergency services and extended hour urgent care under one roof. These facilities will be built in highly convenient retail locations, offering patients easy access to treatment for everything from the common cold …

Venus Concept Ltd. is pleased to announce that it has completed its acquisition of NeoGraft Solutions’ hair restoration business (NeoGraft). Glenn Normoyle, President of NeoGraft, also commented on the acquisition: “We are very happy to join the Venus Concept family. Having spent time with the Venus Concept team, there is consistency in culture and vision between the two companies and …

Spineology Inc. is excited to announce that enrollment is now complete in the Company’s SCOUT clinical trial. The SCOUT (Spineology Clinical Outcomes Trial) IDE, conducted under an FDA-approved protocol, is a prospective multicenter non-randomized performance goal investigation, designed to evaluate safety and effectiveness outcomes in instrumented lumbar interbody fusion procedures for the treatment of degenerative disc disease (DDD). Spineology’s deployable …

LivaNova PLC announced it has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The Pittsburgh-based company offers four product systems, all built around a common pump and controller. These systems, which include ExtraCorporeal Life Support (“ECLS”) and Percutaneous Mechanical Circulatory Support (“pMCS”), are complementary to LivaNova’s strong offerings in …